InvestorsHub Logo
Followers 74
Posts 1863
Boards Moderated 0
Alias Born 04/30/2011

Re: None

Thursday, 11/05/2015 10:27:40 AM

Thursday, November 05, 2015 10:27:40 AM

Post# of 3443

http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-newsArticle&ID=2107366
Idera Pharmaceuticals to Present Phase 1/2 IMO-8400 Clinical Data in Waldenstrom’s Macroglobulinemia at the 2015 American Society of Hematology Annual Meeting

- Poster Presentation to Reveal First Clinical Data for IMO-8400 as Potential Treatment for Waldenström’s Macroglobulinemia -